Atlas Trials

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Clinical trial NCT02072434 · COMPLETED

Trial details

NCT number
NCT02072434
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2014-03-25
Primary completion
2016-02-03
Enrollment
2199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.